Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2318
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs ; volume:17 ; number:1 ; day:10 ; month:10 ; year:2017 ; pages:1-9 ; date:12.2017
BMC geriatrics ; 17, Heft 1 (10.10.2017), 1-9, 12.2017
- Schlagwort
-
Augenheilkunde
Augenkrankheit
- Urheber
-
Péntek, Márta
- Beteiligte Personen und Organisationen
-
Brodszky, Valentin
Biró, Zsolt
Kölkedi, Zsófia
Dunai, Árpád
Németh, János
Baji, Petra
Rencz, Fanni
Gulácsi, László
Resch, Miklós D.
SpringerLink (Online service)
- DOI
-
10.1186/s12877-017-0619-9
- URN
-
urn:nbn:de:1111-2018011211235
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Péntek, Márta
- Brodszky, Valentin
- Biró, Zsolt
- Kölkedi, Zsófia
- Dunai, Árpád
- Németh, János
- Baji, Petra
- Rencz, Fanni
- Gulácsi, László
- Resch, Miklós D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
Retinal layers changes in patients with age-related macular degeneration treated with intravitreal anti-VEGF agents
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Refractory neovascular age-related macular degeneration: time-dependent changes of central retinal thickness with anti-VEGF treatment
The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage
Anti-VEGF for the management of diabetic macular edema
Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy
Hyperreflective material evolution patterns during long term anti-VEGF therapy in neovascular age-related macular degeneration
A Systematic Review of the Treat and Extend Treatment Regimen with Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
Retinal layers changes in patients with age-related macular degeneration treated with intravitreal anti-VEGF agents
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Refractory neovascular age-related macular degeneration: time-dependent changes of central retinal thickness with anti-VEGF treatment
The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage
Anti-VEGF for the management of diabetic macular edema
Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy
Hyperreflective material evolution patterns during long term anti-VEGF therapy in neovascular age-related macular degeneration
A Systematic Review of the Treat and Extend Treatment Regimen with Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
Retinal layers changes in patients with age-related macular degeneration treated with intravitreal anti-VEGF agents
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Refractory neovascular age-related macular degeneration: time-dependent changes of central retinal thickness with anti-VEGF treatment
The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage
Anti-VEGF for the management of diabetic macular edema
Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy
Hyperreflective material evolution patterns during long term anti-VEGF therapy in neovascular age-related macular degeneration
A Systematic Review of the Treat and Extend Treatment Regimen with Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections